1058 related articles for article (PubMed ID: 31147216)
1. circZFR promotes cell proliferation and migration by regulating miR-511/AKT1 axis in hepatocellular carcinoma.
Yang X; Liu L; Zou H; Zheng YW; Wang KP
Dig Liver Dis; 2019 Oct; 51(10):1446-1455. PubMed ID: 31147216
[TBL] [Abstract][Full Text] [Related]
2. Circulating RNA ZFR promotes hepatocellular carcinoma cell proliferation and epithelial-mesenchymal transition process through miR-624-3p/WEE1 axis.
Zhang L; He S; Guan H; Zhao Y; Zhang D
Hepatobiliary Pancreat Dis Int; 2024 Feb; 23(1):52-63. PubMed ID: 37516591
[TBL] [Abstract][Full Text] [Related]
3. CircCCNB1 silencing acting as a miR-106b-5p sponge inhibited GPM6A expression to promote HCC progression by enhancing DYNC1I1 expression and activating the AKT/ERK signaling pathway.
Liu YM; Cao Y; Zhao PS; Wu LY; Lu YM; Wang YL; Zhao JF; Liu XG
Int J Biol Sci; 2022; 18(2):637-651. PubMed ID: 35002514
[No Abstract] [Full Text] [Related]
4. CircZFR promotes hepatocellular carcinoma progression through regulating miR-3619-5p/CTNNB1 axis and activating Wnt/β-catenin pathway.
Tan A; Li Q; Chen L
Arch Biochem Biophys; 2019 Jan; 661():196-202. PubMed ID: 30468709
[TBL] [Abstract][Full Text] [Related]
5. Circ_0091581 Promotes the Progression of Hepatocellular Carcinoma Through Targeting miR-591/FOSL2 Axis.
Ji C; Hong X; Lan B; Lin Y; He Y; Chen J; Liu X; Ye W; Mo Z; She Z; Lin S
Dig Dis Sci; 2021 Sep; 66(9):3074-3085. PubMed ID: 33040214
[TBL] [Abstract][Full Text] [Related]
6. Circ_0015756 promotes proliferation, invasion and migration by microRNA-7-dependent inhibition of FAK in hepatocellular carcinoma.
Liu L; Yang X; Li NF; Lin L; Luo H
Cell Cycle; 2019 Nov; 18(21):2939-2953. PubMed ID: 31522588
[No Abstract] [Full Text] [Related]
7. Circular RNA circZFR Promotes Hepatocellular Carcinoma Progression by Regulating miR-375/HMGA2 Axis.
Xu R; Yin S; Zheng M; Pei X; Ji X
Dig Dis Sci; 2021 Dec; 66(12):4361-4373. PubMed ID: 33433801
[TBL] [Abstract][Full Text] [Related]
8. Circular RNA circ-102,166 acts as a sponge of miR-182 and miR-184 to suppress hepatocellular carcinoma proliferation and invasion.
Li R; Deng Y; Liang J; Hu Z; Li X; Liu H; Wang G; Fu B; Zhang T; Zhang Q; Yang Y; Chen G; Liu W
Cell Oncol (Dordr); 2021 Apr; 44(2):279-295. PubMed ID: 33034848
[TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA PTTG3P functions as an oncogene by sponging miR-383 and up-regulating CCND1 and PARP2 in hepatocellular carcinoma.
Zhou Q; Zhang W; Wang Z; Liu S
BMC Cancer; 2019 Jul; 19(1):731. PubMed ID: 31340767
[TBL] [Abstract][Full Text] [Related]
10. Circular RNA hsa_circ_0005397 promotes hepatocellular carcinoma progression by regulating the miR-326/PDK2 axis.
Gong J; Du C; Sun N; Xiao X; Wu H
J Gene Med; 2021 Jun; 23(6):e3332. PubMed ID: 33783904
[TBL] [Abstract][Full Text] [Related]
11. Circular RNA hsa_circ_103809 suppresses hepatocellular carcinoma proliferation and invasion by sponging miR-620.
Li X; Shen M
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(2):555-566. PubMed ID: 30720163
[TBL] [Abstract][Full Text] [Related]
12. The competing endogenous circular RNA ADAMTS14 suppressed hepatocellular carcinoma progression through regulating microRNA-572/regulator of calcineurin 1.
Song C; Li D; Liu H; Sun H; Liu Z; Zhang L; Hu Y
J Cell Physiol; 2019 Mar; 234(3):2460-2470. PubMed ID: 30317540
[TBL] [Abstract][Full Text] [Related]
13. CircMTO1 suppresses hepatocellular carcinoma progression via the miR-541-5p/ZIC1 axis by regulating Wnt/β-catenin signaling pathway and epithelial-to-mesenchymal transition.
Li D; Zhang J; Yang J; Wang J; Zhang R; Li J; Zhang R
Cell Death Dis; 2021 Dec; 13(1):12. PubMed ID: 34930906
[TBL] [Abstract][Full Text] [Related]
14. Silencing of hsa_circ_0101145 reverses the epithelial-mesenchymal transition in hepatocellular carcinoma via regulation of the miR-548c-3p/LAMC2 axis.
Jin J; Liu H; Jin M; Li W; Xu H; Wei F
Aging (Albany NY); 2020 Jun; 12(12):11623-11635. PubMed ID: 32554866
[TBL] [Abstract][Full Text] [Related]
15. IGF2 Is Up-regulated by Epigenetic Mechanisms in Hepatocellular Carcinomas and Is an Actionable Oncogene Product in Experimental Models.
Martinez-Quetglas I; Pinyol R; Dauch D; Torrecilla S; Tovar V; Moeini A; Alsinet C; Portela A; Rodriguez-Carunchio L; Solé M; Lujambio A; Villanueva A; Thung S; Esteller M; Zender L; Llovet JM
Gastroenterology; 2016 Dec; 151(6):1192-1205. PubMed ID: 27614046
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-98-5p Inhibits Tumorigenesis of Hepatitis B Virus-Related Hepatocellular Carcinoma by Targeting NF-κB-Inducing Kinase.
Fei X; Zhang P; Pan Y; Liu Y
Yonsei Med J; 2020 Jun; 61(6):460-470. PubMed ID: 32469170
[TBL] [Abstract][Full Text] [Related]
17. Hsa_circ_0003998 promotes epithelial to mesenchymal transition of hepatocellular carcinoma by sponging miR-143-3p and PCBP1.
Song LN; Qiao GL; Yu J; Yang CM; Chen Y; Deng ZF; Song LH; Ma LJ; Yan HL
J Exp Clin Cancer Res; 2020 Jun; 39(1):114. PubMed ID: 32552766
[TBL] [Abstract][Full Text] [Related]
18. Long noncoding RNA MIR31HG inhibits hepatocellular carcinoma proliferation and metastasis by sponging microRNA-575 to modulate ST7L expression.
Yan S; Tang Z; Chen K; Liu Y; Yu G; Chen Q; Dang H; Chen F; Ling J; Zhu L; Huang A; Tang H
J Exp Clin Cancer Res; 2018 Sep; 37(1):214. PubMed ID: 30176933
[TBL] [Abstract][Full Text] [Related]
19. LINC00460 promotes hepatocellular carcinoma development through sponging miR-485-5p to up-regulate PAK1.
Tu J; Zhao Z; Xu M; Chen M; Weng Q; Ji J
Biomed Pharmacother; 2019 Oct; 118():109213. PubMed ID: 31376654
[TBL] [Abstract][Full Text] [Related]
20. LncRNA DBH-AS1 facilitates the tumorigenesis of hepatocellular carcinoma by targeting miR-138 via FAK/Src/ERK pathway.
Bao J; Chen X; Hou Y; Kang G; Li Q; Xu Y
Biomed Pharmacother; 2018 Nov; 107():824-833. PubMed ID: 30142544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]